24th May
News Topics
Biotechnology
Education Jobs AlphaTutors™ NEWS

News > biotechnology news

LATEST BIOTECHNOLOGY STORIES

We currently have over 41 articles in this category. We collect together news, analysis and comment from over 34,500 sources.
( Page 1 of 3 ) 2 3

GSK SAYS AMENDS HUMAN GENOME TENDER OFFER CONDITIONS


LONDON (Reuters) - GlaxoSmithKline said it amended the conditions of its tender offer to acquire U.S. biotechnology company Human Genome Sciences in a...

HUMAN GENOME ADOPTS RIGHTS PLAN TO WARD OFF GLAXO


(Reuters) - Human Genome Sciences Inc said on Thursday it adopted a stockholder rights plan as the biotechnology company defends itself against a $2.6...

HUMAN GENOME ADOPTS RIGHTS PLAN TO WARD OFF GLAXO


(Reuters) - Human Genome Sciences Inc said on Thursday it had adopted a stockholder rights plan as the biotechnology company defends itself against a ...

GSK STARTS $2.6 BILLION TENDER OFFER FOR HUMAN GENOME


LONDON (Reuters) - GlaxoSmithKline launched its promised $2.6 billion (1.6 billion pounds) tender for shares in long-time partner Human Genome Science...

INTEL MAKES $75M SPLASH FOR WIRELESS PATENTS


Shaun Nichols, V3.co.uk Company agrees to purchase properties from Aware Inc Intel has inked a $75m deal to acquire patents from biotechnology and t...

ASTRA FUELS BIOTECH M&A WITH $1.26 BILLION ARDEA BUY

LONDON (Reuters) - AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion (782.31 million pounds), giving it a new gout drug t...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
1 month ago

ASTRAZENECA SAYS TO BUY ARDEA BIOSCIENCES FOR $1.26 BLN

Anglo-Swedish drugs giant AstraZeneca on Monday said it had agreed to buy US biotechnology company Ardea Biosciences in a deal worth around $1.26 bill...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
1 month ago

VCS INVESTED $5.8B IN 758 DEALS IN Q1 2012, TOTAL DOLLARS AND DEALS BOTH DOWN FROM LAST QUARTER

Venture capitalists invested $5.8 billion in 758 deals in the first quarter of 2012, according to a MoneyTree Report from PricewaterhouseCoopers LLP a...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
1 month ago

ABBOTT DRUG TOPS SALES AS LIPITOR, PLAVIX ERA ENDS

LONDON (Reuters) - Abbott Laboratories' $9-billion arthritis drug Humira is set to take the crown as the world's top-selling medicine this y...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
1 month ago

AMGEN, ASTRA TO COLLABORATE ON SEVERAL DRUGS

(Reuters) - Amgen Inc and British drugmaker AstraZeneca Plc announced on Monday a major collaboration deal to jointly develop and sell five biotech dr...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
2 months ago

THE JOBS ACT: SUPPORT GROWING BIOTECH COMPANIES DEVELOPING BREAKTHROUGH MEDICINES

Small biotechnology companies are leading innovation across the country. My company, OncoMed Pharmaceuticals, is working at the cutting edge of oncolo...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
2 months ago

US SUPREME COURT REJECTS BLOOD MONITORING PATENTS

Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
2 months ago

WELLCOME TRUST TO LAUNCH 200 MILLION POUNDS BIOTECH FUND

LONDON (Reuters) - The Wellcome Trust medical charity is creating a new 200 million pounds ($318 million) fund to make long-term investments in start-...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
2 months ago

SHIRE TO BUY U.S. BIOTECH FIRM FOR UP TO 207 MILLION POUNDS

(Reuters) - UK drugmaker Shire Plc said it would buy privately held biotechnology firm FerroKin BioSciences for up to 207 million pounds, including an...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
2 months ago

ASTRAZENECA GETS SERIOUS ON DEALS AS DRUGS RUN OUT

LONDON (Reuters) - AstraZeneca is dusting off its cheque book. The country's second biggest drugmaker has bought nothing for more than $400 milli...[ BIOTECHNOLOGY ARTICLES, ANALYSIS]
2 months ago
( Page 1 of 3 ) 2 3
Popular World News
Copyright © 2012 AlphaTutors Ltd. All rights reserved. All third party trademarks are hereby acknowledged.